Verici Dx Plc - Hybridan Small Cap Feast: 11 August 2026
The Company that develops mixed-signal, RF and microwave semiconductors for global communications markets updated on trading before holding its AGM...
97 Views
No more insights
𝛼SK or SearchENTITY
Verici Dx (VRCI LN)
Verici Dx (VRCI LN)
1
Analysis
Health Care • United States
Verici Dx is an immuno-diagnostics development company focused on prognostic and diagnostic tests for kidney transplant patients. The company develops a suite of proprietary tests including Clarava, Tuteva, and Protega, utilizing AI-assisted transcriptomic analysis to provide RNA signatures for personalized patient and organ response risk. Verici Dx was founded in 2020 and is headquartered in Cardiff, United Kingdom.
morex